
BeOne Medicines Ltd. (ONC) climbs 12.8% on ASCO data
BeOne Medicines Ltd. (ONC) climbs after hours as investors react to fresh ASCO 2026 pipeline data and a bullish analyst target hike. The move reflects growing confidence in the company’s commercial oncology business and its expanding solid-tumor pipeline.










